Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Matrix Capital Management Company, LP reported a 0% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13D/A)
Event Dec 30, 2025 · Filed Jan 2, 2026
Matrix Capital Management Company, LP reported a 0% stake in Zentalis Pharmaceuticals, Inc., 0 shares, with active intent on Dec 30, 2025. Filed Jan 2, 2026 (Schedule 13D/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Matrix Capital Management Company, LP | 0% | 0 |
| David E. Goel | 0% | 0 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Matrix Capital Management Company, LP
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Matrix Capital Management Company, LP · Dec 15, 2025
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026